Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Silver diamine fluoride** is a topical inorganic silver(I)-fluoride coordination compound, commonly formulated as a 38% aqueous solution, used in dentistry to relieve dentinal hypersensitivity and to prevent or arrest dental caries. The silver component provides broad local antimicrobial activity against cariogenic microorganisms, while fluoride promotes remineralization and formation of acid-resistant fluoridated apatite in demineralized enamel and dentin. In the United States, the marketed 38% product Advantage Arrest is FDA-cleared as a prescription dental device for dentinal hypersensitivity; use for caries arrest is off-label, although it has been studied extensively, including Phase III trials in cavitated caries. A clinically important limitation is permanent black discoloration of arrested carious lesions. ([ada.org](https://www.ada.org/resources/ada-library/oral-health-topics/silver-diamine-fluoride))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silver diamine fluoride.